R
Rukmani
About Rukmani
Data last updated:
Rukmani is a Director at Supernova Pharmaceuticals Private Limited (since 2018). The company operates in Pharma. Supernova Pharmaceuticals Private Limited reported revenue of ₹3.9 Lakh (FY 2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Supernova Pharmaceuticals Private Limited U74999DL2016PTC304616 | Director | 24 Nov 2018 | 2016 | ₹3.9 Lakh (FY 2019) | Active |
Board colleagues of Rukmani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amardeep Kaur | 08048549 | Supernova Pharmaceuticals Private Limited | Director |
| Devi Dayal | 00700141 | Supernova Pharmaceuticals Private Limited | Director |
| Mohan Singh Rawat | 08278081 | Supernova Pharmaceuticals Private Limited | Director |
| Om Prakash Tanwar | 08812901 | Supernova Pharmaceuticals Private Limited | Director |
| Rahul Malik | 03609363 | Supernova Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rukmani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rukmani
Rukmani currently holds 1 directorship: Supernova Pharmaceuticals Private Limited (Director, since 24 Nov 2018, revenue ₹3.9 Lakh (FY 2019)).
Rukmani was first appointed on 24 Nov 2018 as Director at Supernova Pharmaceuticals Private Limited.
The current boards of Rukmani's companies include Amardeep Kaur (Supernova Pharmaceuticals Private Limited), Devi Dayal (Supernova Pharmaceuticals Private Limited), Mohan Singh Rawat (Supernova Pharmaceuticals Private Limited), Om Prakash Tanwar (Supernova Pharmaceuticals Private Limited), Rahul Malik (Supernova Pharmaceuticals Private Limited).